Milestones｜Institute for Biotechnology and Medicine Industry│IBMI

2024

SNQ 2023 Award Ceremony

2023

2022

2021

IBMI Annual General Gathering 2021, with the presence of Vice President Lai, the founder at Delta Electronics and the Minister of National Development Council
President Tsai received the 23rd National Biotechnology and Medical Care Quality Award (2020) winners in honour of their achievements incl. treating Fabry’s and lymphatic obstruction
Leaders representing the technology and finance sectors- Kou-I Yeh (葉國一), Thomas WU (吳東亮) and Richard M. Tsai (蔡明興) joined IBMI to further develop the healthcare industry
IBMI in partnership with the Taiwan Display Union Association (TDUA): crack open the market for high-end medical displays
IBMI unveiled three strategies for alleviating healthcare workloads and public panic
IBMI responded in an announcement to Emergency Use Authorisation (EUA) evaluation process for and trends on Covid-19 vaccines

2020

Shyi-Kun Yu, Minister of Legislative Yuan, assumed a role as the president of the General Assembly of Healthcare⁺ Expo
IBMI president Chi-Huey Wong submitted the article of 2019-nCov, indicating trends and development of the virus research
The 22^nd National Biotechnology and Medical Care Quality Award (2019) winners were received by President Tsai: Taiwan demonstrates the excellence in medicine and public health
IBMI initiated five industry forums on ‘Taiwan’s Response to Covid-19: Every Crisis Lies an Opportunity’
IBMI released the 2020 White Paper: Industry Development Strategies for the Healthcare Industry in the post-COVID economy
IBMI VP Pan-Chyr Yang addressed at the Third Wednesday Club on trends of healthcare in the post-COVID era
IBMI board meeting: Key missions for 2020 revealed
Media interviews with IBMI president Chi-Huey Wong
- Economic Daily: Taiwan’s strengths of biotechnology
- CNA News: Taiwan’s key to success in developing the healthcare industry
- Global View by CEO Hsieh: When biomedicine meets ICT
- Discovery Channel: Taiwan’s achievements in biomedical technology
The former VP of Taiwan Chien-Jen Chen assumed a role as the Chief Counsellor at IBMI
IBMI VP Yang addressed in a forum hosted by Economic Daily on post-COVID emerging trends with biomedicine, ICT and AI

President and VP IBMI visited Pegatron Corporation with the board of directors
IBMI co-hosted the “Cross-Industry Leadership Talks on Health Innovation” forum with Taiwan Display Union Association (TDUA)
IBMI co-hosted the Digital Health Taiwan Forum with KPMG
President Tsai at the Healthcare+ Expo: Pledge digital transformation in the healthcare industry and access to supplies necessary to Covid-19

2019

2018

2017

IBMI Annual General Gathering 2017: Focusing healthcare industrial trends and innovations
Vice President Chen received the National Biotechnology and Medical Care Quality Award 2016 winners in honour of their achievements in such as liver transplant examination, mandibular reconstruction for head and neck defeats
Launched the Biotechnology and Medical Industry Management Conference, followed by the white paper submitted with highlights of 1) Regulatory & Clinical Resources Integration, 2) R&D, Clinical Trial and Manufacturing, 3) Funding, Financing & IPO and 4) Access to Markets & Talents
IBMI chairman Jyn-Pyng Wang appealed for cooperation to pave the way for industry development
IBMI announcement: Supporting the government to develop the healthcare industry
IBMI signed the Quadrilateral Biomedical Innovation Cooperation Agreement with the China Pharmaceutical Innovation and Research Development Association, HK Bio-Med Innotech Association, and the Macau International Traditional Chinese Medicine Development Association
IBMI chairman Wang visited the Executive Yuan with industry representatives
Hosted inaugural Healthcare⁺ Expo- the world’s first trade fair featuring medicine and technology whilst connecting healthcare supply chains
IBMI participated in the China Biomed Innovation and Investment Conference and a seminar on Taiwan-Hong Kong financing strategies
Awarding ceremony: The 20^th National Biotechnology and Medical Care Quality Award

2016

IBMI meeting with President- and Vice-President-elect in their FAM trips to the biotech industry
Amgen visited IBMI
Co-hosted the second Cross-Strait Biotechnology and New Pharmaceutical Industry Cooperation Forum and Business Mission with the China Pharmaceutical Innovation and Research Development Association
The cross-strait clinical trials “4+4” was given the green light
IBMI urged the government to fulfil the manifesto for developing biotechnology
IBMI president Wei-Chao Chen conferred Hon. D.Sc.by China Medical University
IBMI formed the fifth board of directors (2016-2018), prof. Wei-Chao Chen elected as Honorary President and Dr San-Cheng Chang succeeded as President
Hosted a series of seminars focusing “Cooperation strategies and practices for the biomedical industry”
Co-hosted the Asia Pacific Biotech Investment Forum 2016 with Diamond Biofund
Interview by Economic Daily: IBMI president Chang listed priorities in biotech industry development
A delegation led by the International Research-Based Pharmaceutical Manufacturers Association (IRPMA) visited IBMI
French Office in Taipei visited IBMI to facilitate France-Taiwan industry cooperation
Hosted the Annual Industry Summit- Global M&A Trends and Strategy Forum
Hosted a seminar on “Collaborative models for technology transfer and commercialisation”
IBMI delegation to China with aims at cross-strait collaboration in clinical trials
IBMI Annual General Gathering and the 13^th National Innovation Award ceremony
Launched Taiwan Healthcare⁺ online portal and the 19^th National Biotechnology and Medical Care Quality Award ceremony
Released the Annual Review: Biomedical Industry 2016, covering numbers and insights ranging from industry growth, capital investment, R&D activities through to international network

2015

IBMI founder Jyn-Pyng Wang conferred Hon. D.Sc.by China Medical University
Promoted the use of new drugs and medical devices incorporated under the Act for the Development of Biotech and New Pharmaceuticals Industry, as part of the evaluation criteria of the Hospital Accreditation in Taiwan
Co-hosted the forum “Opportunities and Challenges for the Biopharmaceutical Industry under TPP and RCEP” with the Ministry of Economic Affairs
Publicised the “Bio Taiwan Highlights” and “Top Healthcare in Taiwan”
Hosted the Annual Industry Summit 2016: International Strategy Summit of Bioeconomic Industry
Vice President Den-Yih Wu issued the certificate for Symbol of National Quality (SNQ)
The 18^th National Biotechnology and Medical Care Quality Award ceremony
Ceremony for the 12^th National Innovation Award and opening of university startups and spin-offs

2014

Hosted the three-day forum “Hospital Management and Biomedical Industry Development”
President Ma received the National Biotechnology and Medical Care Quality Award 2013 winners in honour of their achievements in such as atrial fibrillation ablation
“Cross-strait Cooperation Agreement in Healthcare: Review and Recommendations” by IBMI
IBMI Chief Consultant Dr. Wong won the 2014 Wolf Prize in Chemistry
Hosted the forum “Cross-Strait Cooperation in Clinical Trial and Pharmaceutical R&D”, promoting bilateral cooperation whilst avoiding duplication of trials
Co-hosted the Asia Pacific Biotech Investment Forum 2016 with Diamond Biofund: the Upcoming Competition and Cooperation in Biotechnology in Asia
Hosted inaugural “Cross-Strait Biomedical Industry Cooperation” forum, attracting 11 Chinese pharmaceutical groups to explore opportunities in Taiwan
RBMP and the Board of Science and Technology at the Executive Yuan announced the progress of 33 biomedical policies
Ceremony for the 11^th National Innovation Award and opening of university startups and spin-offs
The 17^th National Biotechnology and Medical Care Quality Award ceremony

2013

IBMI response to news reports “Promises of Biomedical Policies Broken”
President Ma received the National Biotechnology and Medical Care Quality Award 2012 winners
Minister Jyn-Pyng Wang of the Legislative Yuan congratulated IBMI executive director Pan-Chyr Yang elected as the principal of National Taiwan University
Announced draft amendments to the Act for the Development of Biotech and New Pharmaceuticals Industry
Research Center for Biotechnology and Medicine Policy (RBMP) board meeting
Published “What happened to my kidney?”, a general science book contributed by 48 medical doctors
Released “Annual Review: Biomedical Industry 2013, focusing on policy, operation, R&D”
Hosted 2013 International BioMedical Venture Forum
Released “Bio Taiwan Highlights” that covered operation analysis of biomedical companies and the survey results of new drugs R&D
Hosted the “Food Safety: Risk, Management & Assessment” forum, concluded with 6 policy advices
The National Innovation Award, the National Biotechnology and Medical Care Quality Award honoured the Award winners in their achievements at the joint awarding ceremony
Visited chairman Pin-Kung Chiang at the Straits Exchange Foundation
Visited Vice President Den-Yih Wu and discussed cross-strait cooperation in healthcare

2012

Marked the 10th anniversary of IBMI and office relocated to the Nangang Software Park
Annual Review: Biomedical Industry, from preparation to follow-up actions
The Industrial College of Armed Forces (ICAF) visited IBMI
Information session: Commercialisation of biomedical technologies and the National Innovation Award
Announced the result of election for the fourth board of directors
The office for cross-strait pharmaceutical cooperation promotion established
Completion of screening process for a hundred of technologies, having had TWD$3bn seed funding in place
University of Wisconsin delegation visited IBMI
IBMI response to news reports regarding cross-strait pharmaceutical cooperation
The National Biotechnology and Medical Care Quality Award 2012 celebrated its 15^th anniversary

2011-2002

IBMI president Chen awarded the Order of Brilliant Star with Grand Cordon in recognition of his dedication to medical education and research, cross-strait health collaboration and promotion for biomedical quality
Propelled cross-strait collaboration in pharmaceuticals and clinical trials, with eight hospitals from both sides involved in Good clinical practice (GCP)
IBMI accelerated agreement on cross-strait healthcare cooperation signed during the sixth Chiang-Chen Talk
Contributed to the overall inspection of biomedical policies, facilitated the Amendment of the Fundamental Science and Technology Act, the Human Biobank Management Act, and the Medical Care Act amendments
Assisted the Centers of Disease Control and Prevention with developing feasibility assessment of products for epidemic management and prevention
Formed the third board of directors (2009-2011), Jin-Pyng Wang elected as IBMI Founder, Prof. Wei-Chao Chen as President and Chi-Huey Wong as Chief Counsellor.
IBMI delegation to China, reached an agreement upon cross-strait cooperation in healthcare
Operated a policy think tank to consolidate industry responses to biomedical policies
Assisted the government with tax credit regulations for expense in R&D and talent development, under the Development of Biotech and New Pharmaceuticals Industry Act
Hosted a forum to accelerate biomedical industry and new drugs development, promoted and boosted the setting of TFDA
Launched the office for research in technologies to prevent chronic kidney disease, integrate a database for kidney disease and study epidemics and high-risk patients
Promoted legislation of the Biotech and New Pharmaceutical Development Act
Launched the office for research and development in tuberculosis prevention and treatment under CDC’s programme for “Reducing TB cases by Half in Ten Years”
Established the certification criteria for the Symbol of National Quality
Assisted the Department of Chinese Medicine and Pharmacy Committee with GMP transformation guidance for traditional Chinese medicine pharmaceuticals
Initiated the National Innovation Award in recognition of R&D and innovation achievements in healthcare
Publicised the “Guide to Taiwan’s Biotechnology Law” and the “Yearbook of Biomedical Trends in Taiwan”
Commenced the process of the National Biotechnology and Medical Care Quality Award recipient selection, announcement and awarding
Organised public hearings for the relaxation of Health Food Control Act that set a framework of ‘evidence-based’ or ‘specification standards’ applied to health food
Founded the Institute for Biotechnology and Medicine Industry (IBMI), inviting the President of Taiwan to host inauguration and mark the start of IBMI leadership by Jin-Pyng Wang along with the board of directors